Adalimumab in the management of psoriasis and psoriatic arthritis: Results from a Delphi investigation
{{output}}
Background and objectives: Psoriasis (PsO) and psoriatic arthritis (PsA) are often undertreated and require a multidisciplinary approach. In recent years, patent expiration has allowed the introduction of tumor necrosis factor in... ...
